| Literature DB >> 33331986 |
Fei Song1, Xiao-Xia Zhou1, Yu Hu1, Gang Li2, Yan Wang3.
Abstract
The insulin-like growth factor (IGF) system comprises ligands of IGF-I/II, IGF receptors (IGFR), IGF binding proteins (IGFBPs), and IGFBP hydrolases. The IGF system plays multiple roles during various disease development as IGFs are widely involved in cell proliferation and differentiation through regulating DNA transcription. Meanwhile, IGFBPs, which are mainly synthesized in the liver, can bind to IGFs and perform two different functions: either inhibition of IGFs by forming inactive compounds with IGF or enhancement of the function of IGFs by strengthening the IGF-IGFR interaction. Interestingly, IGFBPs may have wider functions through IGF-independent mechanisms. Studies have shown that IGFBPs play important roles in cardiovascular disease, tumor progression, fetal growth, and neuro-nutrition. In this review, we emphasize that different IGFBP family members have common or unique functions in numerous diseases; moreover, IGFBPs may serve as biomarkers for disease diagnosis and prediction.Entities:
Keywords: Disease development; Insulin-like growth factor binding proteins; Insulin-like growth factors
Mesh:
Substances:
Year: 2020 PMID: 33331986 DOI: 10.1007/s12325-020-01581-x
Source DB: PubMed Journal: Adv Ther ISSN: 0741-238X Impact factor: 3.845